The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sexually Transmitted Disease (STD) Diagnosis-Global Market Insights and Sales Trends 2024
Synopsis
The global Sexually Transmitted Disease (STD) Diagnosis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sexually Transmitted Disease (STD) Diagnosis in various end use industries. The expanding demands from the Government organizations, Hospitals and Diagnostic clinics,, are propelling Sexually Transmitted Disease (STD) Diagnosis market. Chlamydia testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Syphilis testing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sexually Transmitted Disease (STD) Diagnosis market, driven by demand from China, the second largest economy with some signs of stabilising, the Sexually Transmitted Disease (STD) Diagnosis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sexually Transmitted Disease (STD) Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sexually Transmitted Disease (STD) Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sexually Transmitted Disease (STD) Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sexually Transmitted Disease (STD) Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sexually Transmitted Disease (STD) Diagnosis covered in this report include Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux and Bio-Rad, etc.
The global Sexually Transmitted Disease (STD) Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMerieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen
Global Sexually Transmitted Disease (STD) Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sexually Transmitted Disease (STD) Diagnosis market, Segment by Type:
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
Global Sexually Transmitted Disease (STD) Diagnosis market, by Application
Government organizations
Hospitals
Diagnostic clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sexually Transmitted Disease (STD) Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Sexually Transmitted Disease (STD) Diagnosis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sexually Transmitted Disease (STD) Diagnosis in various end use industries. The expanding demands from the Government organizations, Hospitals and Diagnostic clinics,, are propelling Sexually Transmitted Disease (STD) Diagnosis market. Chlamydia testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Syphilis testing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sexually Transmitted Disease (STD) Diagnosis market, driven by demand from China, the second largest economy with some signs of stabilising, the Sexually Transmitted Disease (STD) Diagnosis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sexually Transmitted Disease (STD) Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sexually Transmitted Disease (STD) Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sexually Transmitted Disease (STD) Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sexually Transmitted Disease (STD) Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sexually Transmitted Disease (STD) Diagnosis covered in this report include Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux and Bio-Rad, etc.
The global Sexually Transmitted Disease (STD) Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMerieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen
Global Sexually Transmitted Disease (STD) Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sexually Transmitted Disease (STD) Diagnosis market, Segment by Type:
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
Global Sexually Transmitted Disease (STD) Diagnosis market, by Application
Government organizations
Hospitals
Diagnostic clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sexually Transmitted Disease (STD) Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Sexually Transmitted Disease (STD) Diagnosis
1.1 Sexually Transmitted Disease (STD) Diagnosis Market Overview
1.1.1 Sexually Transmitted Disease (STD) Diagnosis Product Scope
1.1.2 Sexually Transmitted Disease (STD) Diagnosis Market Status and Outlook
1.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2018-2029)
1.4 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Region (2018-2023)
1.5 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2029)
1.6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2029)
1.6.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2029)
1.6.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2029)
1.6.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2029)
1.6.5 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (2018-2029)
2 Sexually Transmitted Disease (STD) Diagnosis Market by Type
2.1 Introduction
2.1.1 Chlamydia testing
2.1.2 Syphilis testing
2.1.3 Gonorrhoea testing
2.1.4 Herpes simplex virus testing
2.1.5 Human papilloma virus testing
2.1.6 Human immunodeficiency virus testing
2.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2018-2023)
2.2.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Type (2018-2029)
3 Sexually Transmitted Disease (STD) Diagnosis Market Overview by Application
3.1 Introduction
3.1.1 Government organizations
3.1.2 Hospitals
3.1.3 Diagnostic clinics
3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Application (2018-2023)
3.2.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Breakdown by Application (2018-2029)
4 Sexually Transmitted Disease (STD) Diagnosis Competition Analysis by Players
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sexually Transmitted Disease (STD) Diagnosis as of 2022)
4.3 Date of Key Players Enter into Sexually Transmitted Disease (STD) Diagnosis Market
4.4 Global Top Players Sexually Transmitted Disease (STD) Diagnosis Headquarters and Area Served
4.5 Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
4.6 Competitive Status
4.6.1 Sexually Transmitted Disease (STD) Diagnosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.1.4 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.2.4 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.3.5 Aposcience Recent Developments
5.4 Aposcience
5.4.1 Aposcience Profile
5.4.2 Aposcience Main Business
5.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.4.4 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.4.5 Aposcience Recent Developments
5.5 BCR Diagnostics
5.5.1 BCR Diagnostics Profile
5.5.2 BCR Diagnostics Main Business
5.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.5.4 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.5.5 BCR Diagnostics Recent Developments
5.6 BD Medical
5.6.1 BD Medical Profile
5.6.2 BD Medical Main Business
5.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.6.4 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.6.5 BD Medical Recent Developments
5.7 Biocartis
5.7.1 Biocartis Profile
5.7.2 Biocartis Main Business
5.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.7.4 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.7.5 Biocartis Recent Developments
5.8 BioMerieux
5.8.1 BioMerieux Profile
5.8.2 BioMerieux Main Business
5.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.8.4 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.8.5 BioMerieux Recent Developments
5.9 Bio-Rad
5.9.1 Bio-Rad Profile
5.9.2 Bio-Rad Main Business
5.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.9.4 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.9.5 Bio-Rad Recent Developments
5.10 Cepheid
5.10.1 Cepheid Profile
5.10.2 Cepheid Main Business
5.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.10.4 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.10.5 Cepheid Recent Developments
5.11 Danaher
5.11.1 Danaher Profile
5.11.2 Danaher Main Business
5.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.11.4 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.11.5 Danaher Recent Developments
5.12 DiaSorin
5.12.1 DiaSorin Profile
5.12.2 DiaSorin Main Business
5.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.12.4 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.12.5 DiaSorin Recent Developments
5.13 Quidel
5.13.1 Quidel Profile
5.13.2 Quidel Main Business
5.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.13.4 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.13.5 Quidel Recent Developments
5.14 GenMark Diagnostics
5.14.1 GenMark Diagnostics Profile
5.14.2 GenMark Diagnostics Main Business
5.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.14.4 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.14.5 GenMark Diagnostics Recent Developments
5.15 Hologic
5.15.1 Hologic Profile
5.15.2 Hologic Main Business
5.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.15.4 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.15.5 Hologic Recent Developments
5.16 OraSure Technologies
5.16.1 OraSure Technologies Profile
5.16.2 OraSure Technologies Main Business
5.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.16.4 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.16.5 OraSure Technologies Recent Developments
5.17 Qualigen
5.17.1 Qualigen Profile
5.17.2 Qualigen Main Business
5.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Products, Services and Solutions
5.17.4 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue (US$ Million) & (2018-2023)
5.17.5 Qualigen Recent Developments
6 North America
6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sexually Transmitted Disease (STD) Diagnosis Market Dynamics
11.1 Sexually Transmitted Disease (STD) Diagnosis Industry Trends
11.2 Sexually Transmitted Disease (STD) Diagnosis Market Drivers
11.3 Sexually Transmitted Disease (STD) Diagnosis Market Challenges
11.4 Sexually Transmitted Disease (STD) Diagnosis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
